Payment overview · 2025
General Payments
$209.15
3 reported records · 3 companies
Healthcare provider profile · identity verified
James William Fetchero, D.O.
Allopathic & Osteopathic Physicians|Family Medicine · JACKSONVILLE, FL · NPI 1750301586
Verified facts
What the public records show
CMS Open Payments records show James William Fetchero, D.O. received $209.15 in general payments during 2025 across 3 reported records.
Edwards Lifesciences Corporation accounted for 47.7% of that reported general-payment amount.
The Open Payments records used for this analysis explicitly named 2 associated products.
These records do not establish that a payment influenced prescribing or medical care.
Separate record types
Research & Ownership
Research Payments (direct recipient): not present in the loaded data
Associated Research Funding (for example, named PI): not present in the loaded data
Ownership / Investment: not present in the loaded data
These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.
Who paid this doctor?
Companies in 2025 General Payments
| Reported company | Canonical company | Amount | Share | Records | Year |
|---|---|---|---|---|---|
| Edwards Lifesciences Corporation | Unresolved — no canonical attribution shown | $99.80 | 47.7% | 1 | 2025 |
| ABIOMED | Unresolved — no canonical attribution shown | $78.86 | 37.7% | 1 | 2025 |
| BridgeBio Pharma, Inc. | Unresolved — no canonical attribution shown | $30.49 | 14.6% | 1 | 2025 |
What were the payments for?
Payment categories
| Category | Amount | Records |
|---|---|---|
| Food and Beverage | $209.15 | 3 |
A meal, consulting fee, royalty, and travel payment describe different kinds of reported relationships and should not be interpreted as equivalent.
Analysis 1 · Payment-linked products
Products named in Open Payments records
| Reported product | Type | Reported company | Related amount* | Records | Year |
|---|---|---|---|---|---|
| SAPIEN 3 Ultra RESILIA Normalized: sapien 3 ultra resilia |
Device | Edwards Lifesciences Corporation | $99.80 | 1 | 2025 |
Source payment records
|
|||||
| Attruby Normalized: attruby |
Drug | BridgeBio Pharma, Inc. | $30.49 | 1 | 2025 |
Source payment records
|
|||||
* Product-associated amounts are non-additive because one payment record may name more than one product.
These products were named on specific Open Payments records. A named product does not show that the payment influenced treatment or prescribing.
Public prescribing for products named in payments
No exact normalized or approved-alias overlap was found in the loaded Part D year. This does not mean the doctor never prescribed the product.
The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.
Analysis 2 · Same-company prescribing overlap
Drugs reported in other payments from the same company that also appear in Medicare Part D
This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.
No publishable same-company prescribing overlap was found in the loaded Part D year. This does not mean the doctor never prescribed a drug reported elsewhere by a paying company.
These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.
Public Medicare Part D data
Provider-and-drug rows loaded for 2024
| Brand | Generic | Claims | Beneficiaries |
|---|---|---|---|
| Atorvastatin Calcium | Atorvastatin Calcium | 443 | 130 |
| Lisinopril | Lisinopril | 301 | 91 |
| Amlodipine Besylate | Amlodipine Besylate | 285 | 98 |
| Levothyroxine Sodium | Levothyroxine Sodium | 278 | 80 |
| Omeprazole | Omeprazole | 256 | 71 |
| Gabapentin | Gabapentin | 208 | 63 |
| Alprazolam | Alprazolam | 186 | 36 |
| Losartan Potassium | Losartan Potassium | 177 | 52 |
| Metformin Hcl | Metformin Hcl | 177 | 56 |
| Pantoprazole Sodium | Pantoprazole Sodium | 160 | 47 |
| Zolpidem Tartrate | Zolpidem Tartrate | 145 | 31 |
| Furosemide | Furosemide | 144 | 45 |
| Albuterol Sulfate Hfa | Albuterol Sulfate | 136 | 32 |
| Hydrochlorothiazide | Hydrochlorothiazide | 132 | 38 |
| Tamsulosin Hcl | Tamsulosin Hcl | 121 | 38 |
| Simvastatin | Simvastatin | 117 | 37 |
| Metoprolol Succinate | Metoprolol Succinate | 116 | 35 |
| Clopidogrel | Clopidogrel Bisulfate | 108 | 33 |
| Trazodone Hcl | Trazodone Hcl | 104 | 30 |
| Metoprolol Tartrate | Metoprolol Tartrate | 98 | 28 |
| Ozempic | Semaglutide | 98 | 14 |
| Tramadol Hcl | Tramadol Hcl | 98 | 31 |
| Eliquis | Apixaban | 91 | 22 |
| Tizanidine Hcl | Tizanidine Hcl | 89 | 23 |
| Dextroamphetamine-Amphetamine | Dextroamphetamine/Amphetamine | 88 | 13 |
| Meloxicam | Meloxicam | 88 | 24 |
| Donepezil Hcl | Donepezil Hcl | 87 | 25 |
| Rosuvastatin Calcium | Rosuvastatin Calcium | 86 | 29 |
| Carvedilol | Carvedilol | 84 | 27 |
| Clonazepam | Clonazepam | 73 | 12 |
| Montelukast Sodium | Montelukast Sodium | 73 | 24 |
| Ibuprofen | Ibuprofen | 72 | 19 |
| Escitalopram Oxalate | Escitalopram Oxalate | 71 | 25 |
| Mupirocin | Mupirocin | 71 | 19 |
| Quetiapine Fumarate | Quetiapine Fumarate | 71 | 15 |
| Ondansetron Odt | Ondansetron | 69 | 16 |
| Potassium Chloride | Potassium Chloride | 66 | 24 |
| Allopurinol | Allopurinol | 65 | 22 |
| Diclofenac Sodium | Diclofenac Sodium | 65 | 27 |
| Promethazine Hcl | Promethazine Hcl | 65 | suppressed |
| Amitriptyline Hcl | Amitriptyline Hcl | 60 | 14 |
| Azithromycin | Azithromycin | 60 | 49 |
| Fluticasone Propionate | Fluticasone Propionate | 60 | 26 |
| Buspirone Hcl | Buspirone Hcl | 57 | 15 |
| Dicyclomine Hcl | Dicyclomine Hcl | 57 | suppressed |
| Duloxetine Hcl | Duloxetine Hcl | 57 | 13 |
| Fenofibrate | Fenofibrate | 57 | 16 |
| Fluconazole | Fluconazole | 54 | 17 |
| Meclizine Hcl | Meclizine Hcl | 53 | 20 |
| Lorazepam | Lorazepam | 52 | suppressed |
| Sertraline Hcl | Sertraline Hcl | 51 | 16 |
| Methylprednisolone | Methylprednisolone | 49 | 38 |
| Celecoxib | Celecoxib | 48 | 14 |
| Methocarbamol | Methocarbamol | 48 | 15 |
| Sildenafil Citrate | Sildenafil Citrate | 47 | suppressed |
| Pioglitazone Hcl | Pioglitazone Hcl | 44 | 15 |
| Famotidine | Famotidine | 43 | 12 |
| Baclofen | Baclofen | 42 | 14 |
| Warfarin Sodium | Warfarin Sodium | 42 | suppressed |
| Ciprofloxacin Hcl | Ciprofloxacin Hcl | 40 | 30 |
| Prednisone | Prednisone | 40 | 13 |
| Januvia | Sitagliptin Phosphate | 39 | suppressed |
| Temazepam | Temazepam | 38 | suppressed |
| Alendronate Sodium | Alendronate Sodium | 37 | 15 |
| Trelegy Ellipta | Fluticasone/Umeclidin/Vilanter | 37 | 12 |
| Cyclobenzaprine Hcl | Cyclobenzaprine Hcl | 36 | 11 |
| Farxiga | Dapagliflozin Propanediol | 34 | suppressed |
| Lisinopril-Hydrochlorothiazide | Lisinopril/Hydrochlorothiazide | 34 | 11 |
| Clotrimazole-Betamethasone | Clotrimazole/Betamethasone Dip | 33 | 14 |
| Glimepiride | Glimepiride | 33 | 11 |
| Lamotrigine | Lamotrigine | 33 | suppressed |
| Pravastatin Sodium | Pravastatin Sodium | 33 | 15 |
| Metoclopramide Hcl | Metoclopramide Hcl | 32 | suppressed |
| Symbicort | Budesonide/Formoterol Fumarate | 32 | suppressed |
| Amoxicillin | Amoxicillin | 31 | 20 |
| Linzess | Linaclotide | 31 | suppressed |
| Metformin Hcl Er | Metformin Hcl | 31 | suppressed |
| Ropinirole Hcl | Ropinirole Hcl | 31 | suppressed |
| Hydralazine Hcl | Hydralazine Hcl | 30 | 13 |
| Naproxen | Naproxen | 30 | suppressed |
| Propranolol Hcl | Propranolol Hcl | 30 | suppressed |
| Spironolactone | Spironolactone | 30 | suppressed |
| Valacyclovir | Valacyclovir Hcl | 30 | 12 |
| Aripiprazole | Aripiprazole | 29 | suppressed |
| Citalopram Hbr | Citalopram Hydrobromide | 29 | 12 |
| Hydroxyzine Hcl | Hydroxyzine Hcl | 29 | suppressed |
| Pregabalin | Pregabalin | 29 | suppressed |
| Amoxicillin-Clavulanate Potass | Amoxicillin/Potassium Clav | 28 | 21 |
| Synthroid | Levothyroxine Sodium | 28 | suppressed |
| Lantus Solostar | Insulin Glargine,hum.Rec.Anlog | 27 | suppressed |
| Ondansetron Hcl | Ondansetron Hcl | 26 | suppressed |
| Ketoconazole | Ketoconazole | 25 | suppressed |
| Oxybutynin Chloride Er | Oxybutynin Chloride | 25 | suppressed |
| Sucralfate | Sucralfate | 25 | suppressed |
| Amlodipine Besylate-Benazepril | Amlodipine Besylate/Benazepril | 24 | suppressed |
| Clonidine Hcl | Clonidine Hcl | 24 | suppressed |
| Jardiance | Empagliflozin | 24 | suppressed |
| Lantus | Insulin Glargine,hum.Rec.Anlog | 24 | suppressed |
| Myrbetriq | Mirabegron | 24 | suppressed |
| Nifedipine Er | Nifedipine | 24 | suppressed |
| Topiramate | Topiramate | 24 | suppressed |
| Triamcinolone Acetonide | Triamcinolone Acetonide | 24 | 13 |
| Estradiol | Estradiol | 23 | suppressed |
| Gemtesa | Vibegron | 23 | suppressed |
| Levofloxacin | Levofloxacin | 23 | 15 |
| Testosterone Cypionate | Testosterone Cypionate | 23 | suppressed |
| Diazepam | Diazepam | 21 | suppressed |
| Ezetimibe | Ezetimibe | 21 | suppressed |
| Humalog Kwikpen U-100 | Insulin Lispro | 21 | suppressed |
| Levetiracetam | Levetiracetam | 21 | suppressed |
| Repatha Sureclick | Evolocumab | 21 | suppressed |
| Bumetanide | Bumetanide | 20 | suppressed |
| Sumatriptan Succinate | Sumatriptan Succinate | 20 | suppressed |
| Xarelto | Rivaroxaban | 20 | suppressed |
| Azelastine Hcl | Azelastine Hcl | 19 | suppressed |
| Butalbital-Acetaminophen-Caffe | Butalb/Acetaminophen/Caffeine | 19 | suppressed |
| Esomeprazole Magnesium | Esomeprazole Magnesium | 19 | suppressed |
| Hydroxyzine Pamoate | Hydroxyzine Pamoate | 19 | suppressed |
| Venlafaxine Hcl Er | Venlafaxine Hcl | 19 | suppressed |
| Brilinta | Ticagrelor | 18 | suppressed |
| Fenofibrate | Fenofibrate,micronized | 18 | suppressed |
| Scopolamine | Scopolamine | 18 | suppressed |
| Ultra-Fine Short Pen Needle | Pen Needle, Diabetic | 18 | suppressed |
| Mounjaro | Tirzepatide | 17 | suppressed |
| Vraylar | Cariprazine Hcl | 17 | suppressed |
| Fenofibrate | Fenofibrate Nanocrystallized | 16 | suppressed |
| Losartan-Hydrochlorothiazide | Losartan/Hydrochlorothiazide | 16 | suppressed |
| Bupropion Hcl Sr | Bupropion Hcl | 15 | suppressed |
| Cyanocobalamin Injection | Cyanocobalamin (Vitamin B-12) | 15 | suppressed |
| Entresto | Sacubitril/Valsartan | 15 | suppressed |
| Glipizide | Glipizide | 15 | suppressed |
| Levocetirizine Dihydrochloride | Levocetirizine Dihydrochloride | 15 | suppressed |
| Nystatin | Nystatin | 15 | suppressed |
| Omega-3 Acid Ethyl Esters | Omega-3 Acid Ethyl Esters | 15 | suppressed |
| Ramipril | Ramipril | 15 | suppressed |
| Rybelsus | Semaglutide | 15 | suppressed |
| Triamterene-Hydrochlorothiazid | Triamterene/Hydrochlorothiazid | 15 | suppressed |
| Vitamin D2 | Ergocalciferol (Vitamin D2) | 15 | suppressed |
| Bupropion Xl | Bupropion Hcl | 14 | suppressed |
| Finasteride | Finasteride | 14 | suppressed |
| Fluoxetine Hcl | Fluoxetine Hcl | 14 | suppressed |
| Humalog | Insulin Lispro | 14 | suppressed |
| Megestrol Acetate | Megestrol Acetate | 14 | suppressed |
| Nitroglycerin | Nitroglycerin | 14 | suppressed |
| Oxcarbazepine | Oxcarbazepine | 14 | suppressed |
| Tresiba Flextouch U-100 | Insulin Degludec | 14 | suppressed |
| Valsartan | Valsartan | 14 | suppressed |
| Zaleplon | Zaleplon | 14 | suppressed |
| Apidra Solostar | Insulin Glulisine | 13 | suppressed |
| Divalproex Sodium Er | Divalproex Sodium | 13 | suppressed |
| Sulfamethoxazole-Trimethoprim | Sulfamethoxazole/Trimethoprim | 13 | suppressed |
| Torsemide | Torsemide | 13 | suppressed |
| Ventolin Hfa | Albuterol Sulfate | 13 | suppressed |
| Clonidine | Clonidine | 12 | suppressed |
| Dexlansoprazole Dr | Dexlansoprazole | 12 | suppressed |
| Enalapril Maleate | Enalapril Maleate | 12 | suppressed |
| Eszopiclone | Eszopiclone | 12 | suppressed |
| Glipizide Er | Glipizide | 12 | suppressed |
| Hydrocodone-Acetaminophen | Hydrocodone/Acetaminophen | 12 | suppressed |
| Latanoprost | Latanoprost | 12 | suppressed |
| Levemir Flexpen | Insulin Detemir | 12 | suppressed |
| Rexulti | Brexpiprazole | 12 | suppressed |
| Rizatriptan | Rizatriptan Benzoate | 12 | suppressed |
| Ultra-Fine Mini Pen Needle | Pen Needle, Diabetic | 12 | suppressed |
| Flurbiprofen | Flurbiprofen | 11 | suppressed |
| Hydroxychloroquine Sulfate | Hydroxychloroquine Sulfate | 11 | suppressed |
| Ipratropium Bromide | Ipratropium Bromide | 11 | suppressed |
| Janumet Xr | Sitagliptin Phos/Metformin Hcl | 11 | suppressed |
| Levemir | Insulin Detemir | 11 | suppressed |
| Lovastatin | Lovastatin | 11 | suppressed |
| Methylphenidate Er (La) | Methylphenidate Hcl | 11 | suppressed |
| Modafinil | Modafinil | 11 | suppressed |
| Prolia | Denosumab | 11 | suppressed |
| Synjardy Xr | Empagliflozin/Metformin Hcl | 11 | suppressed |
| Terazosin Hcl | Terazosin Hcl | 11 | suppressed |
| Xifaxan | Rifaximin | 11 | suppressed |
Timeline
Payment and prescribing data by year
Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.
| Year | General Payments | Main payer | Explicit products | Company overlaps | Part D coverage |
|---|---|---|---|---|---|
| 2025 | $209.15 · 3 records | Edwards Lifesciences Corporation | Attruby, SAPIEN 3 Ultra RESILIA | — | — |
| 2024 | — | — | — | — | Complete |
Questions to ask
Questions you could discuss with your doctor
- Are there reasonable alternatives I should understand when we discuss treatment options?
- How should I interpret the industry-payment records shown here in the context of my care?
These are general questions generated from reviewed templates. They are not personalized medical advice.
Sources and limitations
How to read this page
- Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
- Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
- Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
- Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
- When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.
Loaded source releases
| Dataset | Year | Publication | Source |
|---|---|---|---|
| CMS Open Payments — General Payments | 2025 | 2026-06-30 | Original source |
| Medicare Part D Prescribers by Provider and Drug | 2024 | 2026-05-06 | Original source |
| NPPES Data Dissemination V2 | current / reference data | 2026-08-10 | Original source |
Full methodology · Questions & answers · Report a possible error